BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 22930479)

  • 1. Blood biomarkers of methylation in Down syndrome and metabolic simulations using a mathematical model.
    Obeid R; Hartmuth K; Herrmann W; Gortner L; Rohrer TR; Geisel J; Reed MC; Nijhout HF
    Mol Nutr Food Res; 2012 Oct; 56(10):1582-9. PubMed ID: 22930479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma methionine, choline, betaine, and dimethylglycine in relation to colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Nitter M; Norgård B; de Vogel S; Eussen SJ; Meyer K; Ulvik A; Ueland PM; Nygård O; Vollset SE; Bjørge T; Tjønneland A; Hansen L; Boutron-Ruault M; Racine A; Cottet V; Kaaks R; Kühn T; Trichopoulou A; Bamia C; Naska A; Grioni S; Palli D; Panico S; Tumino R; Vineis P; Bueno-de-Mesquita HB; van Kranen H; Peeters PH; Weiderpass E; Dorronsoro M; Jakszyn P; Sánchez M; Argüelles M; Huerta JM; Barricarte A; Johansson M; Ljuslinder I; Khaw K; Wareham N; Freisling H; Duarte-Salles T; Stepien M; Gunter MJ; Riboli E
    Ann Oncol; 2014 Aug; 25(8):1609-15. PubMed ID: 24827130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotransmitter-based strategies for the treatment of cognitive dysfunction in Down syndrome.
    Das D; Phillips C; Hsieh W; Sumanth K; Dang V; Salehi A
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():140-8. PubMed ID: 24842803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APP-dependent alteration of GSK3β activity impairs neurogenesis in the Ts65Dn mouse model of Down syndrome.
    Trazzi S; Fuchs C; De Franceschi M; Mitrugno VM; Bartesaghi R; Ciani E
    Neurobiol Dis; 2014 Jul; 67():24-36. PubMed ID: 24636797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of RCAN1 causes Down syndrome-like immune dysfunction.
    Martin KR; Layton D; Seach N; Corlett A; Barallobre MJ; Arbonés ML; Boyd RL; Scott B; Pritchard MA
    J Med Genet; 2013 Jul; 50(7):444-54. PubMed ID: 23644448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation potential: dietary intake and blood concentrations of one-carbon metabolites and cofactors in rural African women.
    Dominguez-Salas P; Moore SE; Cole D; da Costa KA; Cox SE; Dyer RA; Fulford AJ; Innis SM; Waterland RA; Zeisel SH; Prentice AM; Hennig BJ
    Am J Clin Nutr; 2013 Jun; 97(6):1217-27. PubMed ID: 23576045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of octanoate injection on rat blood-brain barrier.
    Trauner DA; Garrett RS
    Pediatr Neurol; 1985; 1(1):20-2. PubMed ID: 3880386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trisomy 21-driven metabolite alterations are linked to cellular injuries in Down syndrome.
    Liu J; Chen S; Huang G; Wen P; Zhou X; Wu Y
    Cell Mol Life Sci; 2024 Mar; 81(1):112. PubMed ID: 38433139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning based analysis for intellectual disability in Down syndrome.
    Baldo F; Piovesan A; Rakvin M; Ramacieri G; Locatelli C; Lanfranchi S; Onnivello S; Pulina F; Caracausi M; Antonaros F; Lombardi M; Pelleri MC
    Heliyon; 2023 Sep; 9(9):e19444. PubMed ID: 37810082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Population with Down Syndrome: Obesity and the Risk of Cardiovascular Disease and Their Assessment Using Omics Techniques-Review.
    Hetman M; Barg E
    Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.
    Vione B; Ramacieri G; Zavaroni G; Piano A; La Rocca G; Caracausi M; Vitale L; Piovesan A; Gori C; Pirazzoli GL; Strippoli P; Cocchi G; Corvaglia L; Locatelli C; Pelleri MC; Antonaros F
    Front Med (Lausanne); 2022; 9():1006891. PubMed ID: 36530924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical Discrimination of the Down Syndrome-Related Metabolic and Oxidative/Nitrosative Stress Alterations from the Physiologic Age-Related Changes through the Targeted Metabolomic Analysis of Serum.
    Lazzarino G; Amorini AM; Mangione R; Saab MW; Di Stasio E; Di Rosa M; Tavazzi B; Lazzarino G; Onder G; Carfì A
    Antioxidants (Basel); 2022 Jun; 11(6):. PubMed ID: 35740106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trisomy 21 and Assisted Reproductive Technologies: A review.
    Sánchez-Pavón E; Mendoza H; García-Ferreyra J
    JBRA Assist Reprod; 2022 Jan; 26(1):129-141. PubMed ID: 34542250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism navigates neural cell fate in development, aging and neurodegeneration.
    Traxler L; Lagerwall J; Eichhorner S; Stefanoni D; D'Alessandro A; Mertens J
    Dis Model Mech; 2021 Aug; 14(8):. PubMed ID: 34345916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral Oxidation Markers in Down Syndrome Patients: The Better and the Worse.
    Szwajgier D; Baranowska-Wójcik E; Grzelczyk J; Żukiewicz-Sobczak W
    Dis Markers; 2021; 2021():5581139. PubMed ID: 34257747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study on machine learning approach to delineate metabolic signatures in intellectual disability.
    Nikam V; Ranade S; Shaik Mohammad N; Kulkarni M
    Int J Dev Disabil; 2019 Apr; 67(2):94-100. PubMed ID: 34141402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of metabolites involved in bioenergetic pathways reveals a pseudohypoxic state in Down syndrome.
    Pecze L; Randi EB; Szabo C
    Mol Med; 2020 Nov; 26(1):102. PubMed ID: 33167881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions.
    Dierssen M; Fructuoso M; Martínez de Lagrán M; Perluigi M; Barone E
    Front Neurosci; 2020; 14():670. PubMed ID: 32733190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics analysis of children with autism, idiopathic-developmental delays, and Down syndrome.
    Orozco JS; Hertz-Picciotto I; Abbeduto L; Slupsky CM
    Transl Psychiatry; 2019 Oct; 9(1):243. PubMed ID: 31582732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and urinary metabolomic profiles of Down syndrome correlate with alteration of mitochondrial metabolism.
    Caracausi M; Ghini V; Locatelli C; Mericio M; Piovesan A; Antonaros F; Pelleri MC; Vitale L; Vacca RA; Bedetti F; Mimmi MC; Luchinat C; Turano P; Strippoli P; Cocchi G
    Sci Rep; 2018 Feb; 8(1):2977. PubMed ID: 29445163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.